Product Information
NEXLIZET 180-10 MG TABLET is a brand product labeled by Esperion Therapeutics, Inc., priced at $13.8180 per EA under NDC 72426081803. Its NADAC has been published 297 times since Oct 21, 2020.
Strength
180; 10 mg/1; mg/1
Manufacturer
Esperion Therapeutics, Inc.NDC
72426081803
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BEMPEDOIC ACID; EZETIMIBEApproval Type
New Drug (NDA)
FDA Application
NDA211617On Market Since
3/9/2020
Pharmacological Classes
Price Statistics
The NADAC for NEXLIZET 180-10 MG TABLET has been published 297 times since Oct 21, 2020, and over the history we have for it it has risen 30.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.8180 per EA |
|---|---|
| All-time high | $13.8411 (May 13, 2026) |
| All-time low | $10.5564 (Oct 21, 2020) |
| 52-week high | $13.8411 |
| 52-week low | $13.4244 |
| Median price | $12.6664 |
| Average price | $12.5389 |
| Largest weekly change | +9.9% (Jan 12, 2022) |
| Weeks tracked | 297 |
| Tracking since | Oct 21, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Bempedoic Acid and Ezetimibe market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NEXLIZET 180-10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEXLIZET 180-10 MG TABLET, manufactured by Esperion Therapeutics, Inc., is $13.8180 per EA (NDC 72426081803), effective Jun 24, 2026.
How has the price of NEXLIZET 180-10 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEXLIZET 180-10 MG TABLET has risen 30.9%. It has been tracked across 297 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for NEXLIZET 180-10 MG TABLET?
Since Oct 21, 2020, the NADAC for NEXLIZET 180-10 MG TABLET has ranged from a low of $10.5564 (Oct 21, 2020) to a high of $13.8411 (May 13, 2026), with a median of $12.6664 per EA.
Are there cheaper alternatives to NEXLIZET 180-10 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NEXLIZET 180-10 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures NEXLIZET 180-10 MG TABLET?
NEXLIZET 180-10 MG TABLET (NDC 72426081803) is labeled by Esperion Therapeutics, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification